openPR Logo
Press release

Global Intravenous Access Devices Market, By Product Type (IV Catheters, IV Infusion Pumps, IV Needles), Catheters (Midline Peripheral Catheters, Peripherally Inserted Central Catheters, Centrally Inserted Central Catheters), End User (Hospitals and clini

09-15-2017 04:14 PM CET | Health & Medicine

Press release from: Medical Devices Market Report

Global Intravenous Access Devices Market, By Product Type (IV

Intravenous Access Devices – Rise in prevalence of the diseases is anticipated to fuel the demand of intravenous access devices

Intravenous access device can be implanted under the skin which allows the medication to be delivered directly into large veins. Large veins clot less likely and so intravenous access devices can be left inside for long periods. Intravenous access devices are small, flexible tubes placed in large veins for people who require frequent access to the bloodstream. These devices are often also referred as venous access ports or catheters as they allow access to the veins without the use of deep needle stick. Placement of intravenous access devices is usually in one of the large veins of the chest or neck where they can remain in place for long periods such as weeks, months or even longer.

Increase in prevalence of diabetes, road accidents and increase in number of surgical procedures. As per the stats published by Centers for Disease Control and Prevention in the year 2016 more than 29 million Americans are living with diabetes, and 86 million are living with pre-diabetes.

Request a sample copy of this report:

The global intravenous access device market was valued at US$ 34,100.7 million in 2016 and is expected to witness a robust CAGR of 6.6% during the forecast period (2017-2025).

Rise in incidences of different disease is expected to fuel the growth of the intravenous access devices market in the near future.

North America accounts for the largest share in the global intravenous access devices market, followed by Europe. This mainly attributed to rapidly aging population, increase in the incidence rate of various disease such as cancer, kidney failure, diabetes and other life style inflicted diseases are some of the major factors that are expected to drive the intravenous access market. As per the stats published by Centers for Disease Control and Prevention (CDC), in 2012, around 29.1 people were living with diabetes in the U.S. Furthermore, in 2012, 1.7 million people were newly diagnosed for diabetes in U.S.

The intravenous access devices market is expected to show high growth rate in Asia-Pacific region over the forecast period supported by increase in prevalence rate of lifestyle disease such as diabetes. According to World Health Organization (WHO), in 2016, around 110 million people were living with diabetes in China and this number is expected to reach 150 million in 2040 due to unhealthy habits and lack of physical activity.

Also, the intravenous access device are used for administrating all drugs such as antipyretics, antibiotics, and analgesics is expected to raise the demand for the intravenous access device in developed and emerging regions during forecast period, as various drugs are used to treat the patients to get cure rapidly, as the drug can be directly inserted into the body through veins without any contamination. Also, intravenous access devices can be used for longer period of time for frequent intake of drugs.

Ask for customization:

Increase in preference of intravenous access devices for diagnosis of the disease by advance technology is expected to favor the growth of intravenous access devices market

Intravenous access devices are used to perform diagnostic test, blood sampling, blood transfusion, reading central venous pressure and fluid infusion. Intravenous access device is also attributed to rapidly aging population. According to National Institute on Aging in 2010 it was estimated that 524 million people were aged 65 or older that is 8% of the world's population and by 2050, which is expected to nearly triple the number to 1.5 billion, representing 16% of the world's population. This above statistics is expected favor the growth of intravenous access devices market. Whereas latest techniques, such as ultrasound-guided catheter tip have helped to increase the efficiency of these devices.

Some major players operating in the intravenous access devices market includes Becton, Dickinson and Company, B. Braun Melsungen AG, Teleflex, Inc., C.R. Bard, Inc., Fresenius Medical Care, Smiths Medical, Hospira, Inc., Covidien Plc, Fresenius Medical Care AG & Co., and Baxter International.

Click here to know more about this publish report:

Few growth restraining factors are due to prolonged hospitalization required before the intravenous access device is inserted in the body and prolonged placement of the device is limiting the growth of intravenous access device market.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Intravenous Access Devices Market, By Product Type (IV Catheters, IV Infusion Pumps, IV Needles), Catheters (Midline Peripheral Catheters, Peripherally Inserted Central Catheters, Centrally Inserted Central Catheters), End User (Hospitals and clini here

News-ID: 720758 • Views: 245

More Releases from Medical Devices Market Report

Global ENT Disorder Treatment Market to Surpass US$ 10 Billion by 2025
ENT Disorder Treatment Market – Hear Better, Breathe Better, Live Better ENT also known as otolaryngology is a stream of medical science that deals with disorders associated with ear, nose, and throat. Diseases related to ears, throat, and nose significantly affect the quality of life and could lead to surgeries in few cases such as chronic tonsillitis, ear infections, and severe sinusitis problems as well as cancers of the throat or
Endometrial Ablation Market - Global Industry Insights 2025
Endometrial ablation is process that facilitates the destruction of endometrium or thin layer of the uterine wall, in context to treat abnormal heavy uterine bleeding if not controlled with any means of medication. Endometrial ablation is not recommended in women with disorders of endometrium, endometrial hyperplasia, cancer of uterus, recent pregnancy and certain infections of uterus, as per the American College of Obstetrics and Gynecology (ACOG). Depending on technique and
Blood Collection Devices Market - Global Industry Insights 2025
Blood collection devices plays a crucial role in the patient treatment. For the treatment, blood samples are collected to measure the basic metabolism components such as blood urea nitrogen, sodium, potassium, creatinine, magnesium, chloride, and also used to measure blood glucose and lipid levels. In the recent years, as technology has increased in availability and complexity, the experts in the laboratories are receiving wide range of opportunities and challenges. In
Casting and Splinting Products Market - Global Industry Insights 2025
Casts and splints are designed to protect and support injured or fractured joints and bones. They help to immobilize broken bones or dislocated joints in place, until fully healed. A cast is the treatment of choice in fractures where a minimal amount of swelling is expected, including fractures that are non-displaced as well as complicated conditions such as Paige’s, wherein a cast is placed after subsided swelling due to initial

All 5 Releases

More Releases for Intravenous

Intravenous (IV) Solutions Market
The Global Intravenous (IV) Solution Market is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer. Key Finding The global Intravenous (IV) Solution market and is expected to reach USD
Intravenous Solutions Market Opportunity Analysis, 2026
Intravenous solutions are the chemically prepared fluids, which are administered in the body through venous circulation to maintain or replace the lost body fluid level. There are various types of IV solutions that have different effects on a human body. Majority of intravenous solutions constitute of solvent and solute out of which solvents are sterile water and solutes are electrolytes such as sodium, potassium, and chloride. Intravenous solutions market is
Intravenous Product Packaging Market -
Global healthcare sector continues to develop at an impressive rate. As a result, packaging marketplace is undergoing huge changes with specialized focus on offering innovative packaging tools/products to pharmaceutical industry. One such core product that offers lucrative market opportunities for packaging companies is intravenous products. Download PDF Brochure For Future Advancements@ Intravenous product such as catheters and IV fluid bags are mainly used to prevent and treat various chronic illness
Intravenous Iron Drugs Market - Transformation Overview 2025
Intravenous Iron Drugs Market: Snapshot Iron is one of the most significant minerals required for the correct working of human bodies. Iron insufficiency prompts various medical problems, for example, anemia and could have a grave and direct association with the several of hospitalizations and deaths. The global market for intravenous drugs is foreseen to display a solid CAGR over the report's forecast period attributable to the rising pervasiveness of anemia cases
Intravenous Immunoglobulin (IVIg) Market Professional Survey Report
The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from the plasma of more than thousand of blood donors. Individuals who are unable to produce adequate amount of antibodies, such as patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia, get benefit from
Peripheral Intravenous Catheter Market
New research report offers a comprehensive analysis of the “Peripheral Intravenous Catheter Market: Asia Pacific Regional Market to Witness the Fastest Growth Throughout the Forecast Period: Global Industry Analysis & Opportunity Assessment, 2016-2021“The main objective of this report is to deliver insightful information and clear-cut facts pertaining to the growth trajectories of the market. Request to view Sample Report @ Peripheral intravenous catheter is a sophisticated medical device widely used to